ICER to Assess Roxadustat for Treatment Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) announced plans to assess FibroGen's roxadustat for the treatment of anemia in [...]
ISPOR Offers Short Courses on Medical Devices, Payment Models
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering short courses on medical devices and different payment models [...]
PBMs Report Ease in Demand for Hydroxychloroquine
Pharmacy benefit managers last month reported an easing of demand for the antimalarial drug hydroxychloroquine following a rapid surge spurred [...]
Valid Insight Report Explores Insights from Roundtable on Payer Engagement
A new report from Valid Insight explores key insights generated from a roundtable discussion on payer engagement. The white paper, [...]
Podcast Highlights ‘Buy and Bill’ Model in Oncology
Memorial Sloan Kettering Cancer Center's Dr. Aaron Mitchell in the latest Relentless Health Value podcast discusses the "buy and bill" [...]
OptumRx: Rising Orphan Drug Competition Could Lead to Lower Prices
Increased competition in the orphan drug market could ultimately help pull down prices, OptumRx suggests in a new report. According [...]
ACR Tapped as Imaging Partner for COVID-19 Registry
The Society of Clinical Care Medicine (SCCM) has chosen the American College of Radiology (ACR) to be the main imaging [...]
Report: HEOR Services Market Poised for Rapid Growth
The health economics and outcomes research (HEOR) services market is set to see "rapid growth" between 2020-2025, according to a [...]
NPC: ‘Ready, aim, fire’ Mentality Detrimental in Health Care
Having a "ready, aim, fire" mentality can prove harmful when sharing health care information, the National Pharmaceutical Council (NPC) writes [...]
Legislation Aims to Prevent Pharma From Price-gouging During Pandemic
Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 [...]
Report Reveals Racial Disparities in COVID-19 Outcomes
New data released by the government on Monday suggests black Americans under Medicare were roughly four times more likely as [...]
‘Domestic Reference Pricing’ for COVID-19 Drugs?
While the Trump administration has in the past proposed international reference pricing for drug pricing in the U.S., a Health [...]
NPC Plans Webinar in Prices for COVID-19 Drugs
An upcoming webinar hosted by the National Pharmaceutical Council (NPC) will discuss a range of pricing-related issues for COVID-19 drugs. [...]
Hahn: Some COVID-19 Changes to Remain
Food and Drug Administration (FDA) Chief Stephen Hahn recently said some changes made to address COVID-19 will remain in place, [...]
Informa Pharma Intelligence Plans 24-Hour Webinar Series
Informa Pharma Intelligence is set to host a free, 24-hour interactive webinar series on the latest insights into COVID-19. The [...]
Blog Post Explores Novel Value Elements for Assessment of COVID-19 Drugs
A recent Health Affairs blog post suggests the inclusion of more novel value elements in the assessment of COVID-19 drugs [...]
ISPOR-FDA Summit Transitions to Virtual Event
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) announced that the joint ISPOR-FDA Summit 2020, set for Sept. 29, [...]
Cytel Offers On-Demand Access to Webinar on Synethic, External Control Arms
A new on-demand webinar from Cytel offers insights into synthetic and external control arms in clinical trials. The webinar features [...]
Opinion: Move Forward with Evidence-based Care as Foundation
Evidence-based care should be the bedrock of health care moving forward, the authors of a recent opinion piece published on [...]
Cytel Paper Offers Insight into Trial Recruitment Targets
A new white paper from Cytel offers insight into how recruitment targets are "met with sound starting assumptions and key [...]
How Can HEOR Boost Outcomes?
The health economics and outcomes research (HEOR) framework can help facilitate more robust decision-making using "powerful data and insights," ISPOR [...]
Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’
The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided [...]
Kreis: Challenging Price of Costly CF Drug Not ‘Discrimination’
Maurice Kreis, head of the New Hampshire Office of the Consumer Advocate, says challenging the price of Vertex Pharmaceuticals' cystic [...]
Study Suggests Pfizer’s Vyndaqel is Too Expensive
A recent study published in JAMA Cardiology suggests the price tag on Pfizer's Vyndaqel is too high. According to a [...]
Sarepta Therapeutics’ Berry Talks Access to Rare Disease Treatments
Sarepta Therapeutics' Diane Berry in a recent Patients Rising Podcast discussed access to treatments for rare diseases. Berry is Sarepta [...]